Stereophotogrammetric assessment of the effect of tenoxicam on facial swelling subsequent to third molar surgery.
The present study was undertaken in order to evaluate the effects of tenoxicam (Tilcotil), 20 mg daily, versus placebo on the inflammatory response induced in patients undergoing surgical removal of bilateral lower third molar teeth, using stereophotogrammetry to assess the degree of swelling. The results indicated that tenoxicam (20 mg/day) was no more effective than a nonactive placebo in modifying swelling in the first two postoperative days.
Uçok
C
C
Department of Oral and Maxillofacial Surgery, Dental Faculty, Ankara University, Turkey.
D000328:Adult; D000704:Analysis of Variance; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004487:Edema / Q000473:pathology / Q000517:prevention & control*; D005069:Evaluation Studies as Topic; D005145:Face; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008334:Mandible; D008964:Molar, Third / Q000601:surgery*; D010780:Photogrammetry; D010894:Piroxicam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010919:Placebos; D014081:Tooth Extraction / Q000009:adverse effects*; D014095:Tooth, Impacted / Q000601:surgery
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010919:Placebos; D010894:Piroxicam; C032801:tenoxicam